ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968

Cancer Letters

Volumn 292, Issue 2, 2010, Pages 186-196

  Zuco, Valentina ^a   Benedetti, Valentina ^a   Zunino, Franco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Apoptosis; Camptothecin; DNA damage response; Mitotic catastrophe; Senescence

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CAMPTOTHECIN; CHECKPOINT KINASE 1; ST 1968; UNCLASSIFIED DRUG; ATR PROTEIN, HUMAN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; DRUG DERIVATIVE; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME INHIBITION; GENE ACTIVATION; HUMAN; HUMAN CELL; IONIZING RADIATION; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; CELL CYCLE; DNA DAMAGE; FEMALE; INFRARED RADIATION; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

CAMPTOTHECIN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; DNA-BINDING PROTEINS; FEMALE; HUMANS; INFRARED RAYS; OVARIAN NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 77951909740     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.12.001     Document Type: Article

References (32)

1. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 2006, 6:789-802.
2. Beretta G.L., Zunino F. Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activity. Biochem. Pharmacol. 2007, 74:1437-1444.
3. Roos W.P., Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 2006, 12:440-450.
4. Bartek J., Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr. Opin. Cell. Biol. 2007, 19:238-245.
5. Iliakis G., Wang Y., Guan J., Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003, 22:5834-5847.
6. Yang J., Yu Y., Hamrick H.E., Duerksen-Hughes P.J. ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses. Carcinogenesis 2003, 24:1571-1580.
7. Xiao Z., Chen Z., Gunasekera A.H., Sowin T.J., Rosenberg S.H., Fesik S., Zhang H. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J. Biol. Chem. 2003, 278:21767-21773.
8. Flatten K., Dai N.T., Vroman B.T., Loegering D., Erlichman C., Karnitz L.M., Kaufmann S.H. The role of checkpoint kinase 1 in sensitivity to topoisomerase I poisons. J. Biol. Chem. 2005, 280:14349-14355.
9. Cliby W.A., Lewis K.A., Lilly K.K., Kaufmann S.H. S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function. J. Biol. Chem. 2002, 277:1599-1606.
10. Pisano C., Zuco V., De Cesare M., Benedetti V., Vesci L., Foderà R., Bucci F., Aulicino C., Penco S., Carminati P., Zunino F. Intracellular accumulation and DNA damage persistence as determinants of human squamous cell carcinoma hypersensitivity to the novel camptothecin ST1968. Eur. J. Cancer 2008, 44:1332-1340.
11. Zuco V., Zunino F. Cyclic pifithrin-alpha sensitizes wild type p53 tumor cells to antimicrotubule agent-induced apoptosis. Neoplasia 2008, 10:587-596.
12. Illidge T.M., Cragg M.S., Fringes B., Olive P., Erenpreisa J.A. Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage. Cell. Biol. Int. 2000, 24:621-633.
13. Jonathan E.C., Bernhard E.J., McKenna W.G. How does radiation kill cells?. Curr. Opin. Chem. Biol. 1999, 3:77-83.
14. Zuco V., Zanchi C., Cassinelli G., Lanzi C., Supino R., Pisano C., Zanier R., Giordano V., Garattini E., Zunino F. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid. Cell Death Differ. 2004, 11:280-289.
15. Wu X., Shell S.M., Liu Y., Zou Y. ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation. Oncogene 2007, 26:757-764.
16. Norbury C.J., Zhivotovsky B. DNA damage-induced apoptosis. Oncogene 2004, 23:2797-2808.
17. Tibbetts R.S., Brumbaugh K.M., Williams J.M., Sarkaria J.N., Cliby W.A., Shieh S.Y., Taya Y., Prives C., Abraham R.T. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 1999, 13:152-157.
18. Falck J., Mailand N., Syljuåsen R.G., Bartek J., Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001, 410:842-847.
19. Van Vugt M.A., Medema R.H. Getting in and out of mitosis with polo-like kinase-1. Oncogene 2005, 24:2844-2859.
20. Hickson I., Zhao Y., Richardson C.J., Green S.J., Martin N.M.B., Orr A.I., Reaper P.M., Jackson S.P., Curtin N.J., Smith G.C.M. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004, 64:9152-9159.
21. Teng M., Zhu J., Johnson M.D., Chen P., Kornmann J., Chen E., Blasina A., Register J., Anderes K., Rogers C., Deng Y., Ninkovic S., Grant S., Hu Q., Lundgren K., Peng Z., Kania R.S. Structure-based design of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2′-4′-diols as novel and potent human CDK1 inhibitors. J. Med. Chem. 2007, 50:5253.
22. Arimondo P.B., Thomas C.J., Oussedik K., Baldeyrou B., Maheieu C., Halby L., Guianvarc'h D., Lansiaux A., Hecht S.M., Bailly C., Giovannangeli C. Exploring the cellular activity of camptothecin-triple-helix-forming oligonucleotide conjugates. Mol. Cell. Biol. 2006, 26:324-333.
23. Huang M., Miao Z.-H., Zhu H., Cai Y.-J., Lu W., Ding J. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins. Mol. Cancer Ther. 2008, 7:1440-1449.
24. Larsen A.K., Skladanowski A. Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death. Biochim. Biophys. Acta 1998, 1400:257-274.
25. Mansilla S., Bataller M., Portugal J. Mitotic catastrophe as a consequence of chemotherapy. Anti-cancer Agents Med. Chem. 2006, 6:589-602.
26. Castedo M., Perfettini J.L., Roumier T., Andreau K., Medema R., Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004, 23:2825-2837.
27. Badie C., Itzhaki J.E., Sullivan M.J., Carpenter A.J., Porter A.C. Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells. Mol. Cell. Biol. 2009, 20:2358-2366.
28. Estève P.O., Chin H.G., Pradhan S. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc. Natl. Acad. Sci. USA 2005, 102:1000-1005.
29. Siu W.Y., Lau A., Arooz T., Chow J.P., Ho H.T., Poon R.Y.C. Topoisomerase poisons differentially activated DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms. Mol. Cancer Ther. 2004, 3:621-632.
30. Wang X.Q., Redpath J.L., Fan S.T., Stanbridge E.J. ATR dependent activation of Chk2. J. Cell. Physiol. 2006, 208:613-619.
31. Chen Z., Xiao Z., Gu W.-Z., Xue J., Bui M.H., Kovar P., Li G., Wang G., Tao Z-F., Tong Y., Lin Z.-H., Sham H.L., Wang J.Y.J., Sowin T.J., Rosenberg S.H., Zhang H. Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics. Int. J. Cancer 2006, 119:2784-2794.
32. Vakifahmetoglu H., Olsson M., Tamm C., Heidari N., Orrenius S., Zhivotovsky B. DNA damage induces two distinct modes of cell death in ovarian carcinomas. Cell Death Differ. 2008, 15:555-566.